Home/ Stocks/ CMND

Clearmind Medicine Inc. Common Shares

CMND XNAS

$1.76 -0.05 (-2.87%) ▼ 15-min delayed

Open

$1.82

High

$1.84

Low

$1.73

Volume

22.4K

Market Cap

$2.69M

About Clearmind Medicine Inc. Common Shares

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Employees: 2 Website →

TickerDaily Coverage

Why Is Clearmind Medicine Inc. Common Shares (CMND) Stock Up 58.4% Today?

Penny Stocks Marcus Rivera · May 29, 2026

Clearmind Medicine Inc. Common Shares (CMND) ripped 58.4% higher to $3.88 on Friday, May 29, 2026,...

View All Coverage →

Get CMND Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Clearmind Medicine Inc. Common Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.